Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.50 |
| ▸ | LTA4H | P09960 | 1/20 | 0.49 |
| ▸ | LAP3 | P28838 | 1/20 | 0.49 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CTSB | P07858 | 2/20 | 0.47 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2581152 | 0.84 | ALDH1A1 (0.49) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL8892531 | 0.84 | MMP8 (0.58) | ALDH1A1L3MBTL1KMT2ASRRLMNA | |
| SCHEMBL8939122 | 0.81 | ATM (0.53) | ALDH1A1L3MBTL1KMT2ASRRLMNA | |
| SCHEMBL1555297 | 0.81 | ALDH1A1 (0.57) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL4219709 | 0.79 | ALDH1A1 (0.55) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL7298214 | 0.79 | ALDH1A1 (0.55) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL262278 | 0.79 | ALDH1A1 (0.55) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL4326937 | 0.79 | ALDH1A1 (0.55) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL21811160 | 0.79 | CYP1A2 (0.59) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL8392561 | 0.79 | ALDH1A1 (0.60) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2080779-B1 | POLYMERIC DERIVATIVE OF NUCLEIC ACID METABOLIC ANTAGONIST | NIPPON KAYAKU KK (JP) | 2016-05-18 | — | — | EP | claimed |
| US-8334364-B2 | High-molecular weight derivative of nucleic acid antimetabolite | NIPON KAYAKU KABUSHIKI KAISHA (JP) | 2012-12-18 | — | — | US | claimed |
| EP-1881020-B1 | POLYMERIC DERIVATIVE OF CYTIDINE METABOLIC ANTAGONIST | NIPPON KAYAKU KK (JP) | 2010-08-11 | — | — | EP | claimed |
| US-7700709-B2 | Polymeric derivative of cytidine metabolic antagonist | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2010-04-20 | — | — | US | claimed |
| US-20090281300-A1 | HIGH-MOLECULAR WEIGHT DERIVATIVE OF NUCLEIC ACID ANTIMETABOLITE | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-11-12 | — | — | US | claimed |
| EP-2080779-A1 | POLYMERIC DERIVATIVE OF NUCLEIC ACID METABOLIC ANTAGONIST | Nippon Kayaku Kabushiki Kaisha (JP) | 2009-07-22 | — | — | EP | claimed |
| US-20090012252-A1 | Polymeric Derivative of Cytidine Metabolic Antagonist | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-01-08 | — | — | US | claimed |
| EP-1881020-A1 | POLYMERIC DERIVATIVE OF CYTIDINE METABOLIC ANTAGONIST | Nippon Kayaku Kabushiki Kaisha (JP) | 2008-01-23 | — | — | EP | claimed |
| EP-2080779-B1 | POLYMERIC DERIVATIVE OF NUCLEIC ACID METABOLIC ANTAGONIST | NIPPON KAYAKU KK (JP) | 2016-05-18 | — | — | EP | disclosed |
| US-8334364-B2 | High-molecular weight derivative of nucleic acid antimetabolite | NIPON KAYAKU KABUSHIKI KAISHA (JP) | 2012-12-18 | — | — | US | disclosed |
| EP-1881020-B1 | POLYMERIC DERIVATIVE OF CYTIDINE METABOLIC ANTAGONIST | NIPPON KAYAKU KK (JP) | 2010-08-11 | — | — | EP | disclosed |
| US-7700709-B2 | Polymeric derivative of cytidine metabolic antagonist | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2010-04-20 | — | — | US | disclosed |
| US-20090281300-A1 | HIGH-MOLECULAR WEIGHT DERIVATIVE OF NUCLEIC ACID ANTIMETABOLITE | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-11-12 | — | — | US | disclosed |
| EP-2080779-A1 | POLYMERIC DERIVATIVE OF NUCLEIC ACID METABOLIC ANTAGONIST | Nippon Kayaku Kabushiki Kaisha (JP) | 2009-07-22 | — | — | EP | disclosed |
| US-20090012252-A1 | Polymeric Derivative of Cytidine Metabolic Antagonist | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-01-08 | — | — | US | disclosed |
| EP-1881020-A1 | POLYMERIC DERIVATIVE OF CYTIDINE METABOLIC ANTAGONIST | Nippon Kayaku Kabushiki Kaisha (JP) | 2008-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090281300-A1 | HIGH-MOLECULAR WEIGHT DERIVATIVE OF NUCLEIC ACID ANTIMETABOLITE | POLRMT, POLN, POLI | ALDH1A1 1934/4885TDP1 224/4885MAPK1 3176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.